http://www.clinicaltrials.gov/ct2/show/NCT01231607?term=alopecia&rank=15
They are trying lower dosages than the 2,5mg . It is basically the same that was already done, but it look like Glaxo is still interested. Anyway, the clinical trial is done in several countries but not in USA ( Argentina, Chile , Japan, Peru, Taiwan, etc ). This confuse me a little,since alway is USA and Europe first approved and then the rest.
» CTG Labs - NCBI
» They are trying lower dosages than the 2,5mg . It is basically the same
» that was already done, but it look like Glaxo is still interested. Anyway,
» the clinical trial is done in several countries but not in USA ( Argentina,
» Chile , Japan, Peru, Taiwan, etc ). This confuse me a little,since alway is
» USA and Europe first approved and then the rest.
Glaxo has plainly stated in the past that they’re not going for FDA approval of dutasteride as a treatment for MPB. I think they’re serious about that! I strongly suspect that they’re interested in doing additional Phase 2 trials (yes, it’s just another Phase 2 trial) just to get doctors around the world (even in the USA!) interested in prescribing it off-label for that purpose.